-
Je něco špatně v tomto záznamu ?
Association between fasting plasma triglycerides, all-cause and cardiovascular mortality in Czech population. Results from the HAPIEE study
H. Pikhart, J. A. Hubáček, A. Peasey, R. Kubínová, M. Bobák
Jazyk angličtina Země Česko
Typ dokumentu časopisecké články, multicentrická studie, Research Support, N.I.H., Extramural, práce podpořená grantem
NLK
Directory of Open Access Journals
od 1991
Free Medical Journals
od 1998
ProQuest Central
od 2005-01-01
Medline Complete (EBSCOhost)
od 2006-01-01
Nursing & Allied Health Database (ProQuest)
od 2005-01-01
Health & Medicine (ProQuest)
od 2005-01-01
ROAD: Directory of Open Access Scholarly Resources
od 1998
- MeSH
- kardiovaskulární nemoci krev mortalita MeSH
- lidé středního věku MeSH
- lidé MeSH
- mortalita trendy MeSH
- následné studie MeSH
- omezení příjmu potravy krev MeSH
- rizikové faktory MeSH
- senioři MeSH
- surveillance populace * metody MeSH
- triglyceridy krev MeSH
- Check Tag
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- multicentrická studie MeSH
- práce podpořená grantem MeSH
- Research Support, N.I.H., Extramural MeSH
- Geografické názvy
- Česká republika MeSH
Dyslipidemia is the risk factor of cardiovascular disease, but the relationship between the plasma triglyceride (TG) levels and total/cardiovascular mortality has not yet been analyzed in Slavs. The aim of our study was to analyze the association between the fasting TG levels and all-cause/cardiovascular mortality. We have examined 3,143 males and 3,650 females, aged 58.3+/-7.1 years. 729 deaths (274 cardiovascular deaths) have been registered during up to 11.8 years of follow-up. Age-sex adjusted all-cause mortality was higher in individuals with TG values 3.01-4.00 mmol/l (HR 1.37, 95 % CI 1.02-1.83, P=0.035) and over 4.00 mmol/l (HR 1.66, 95 % CI 1.21-2.27, P=0.002) when compared with a reference group (TG 1.41-1.80 mmol/l). Elevated risk remains significant when adjusted for education, marital status and unemployment. When further adjusted for smoking, BMI and dyslipidemia interventions, HR for those in above 4.00 mmol/l group decreased (1.42, P=0.04). The results have been similar when cardiovascular mortality has been examined, however, results reached statistical significance only for the TG over 4.0 mmol/l (P=0.028). Our results confirmed that enhanced plasma levels of plasma triglycerides are dose dependently associated with increased risk of all-cause mortality, however, it seems that individuals with TG values 1.8-3.0 mmol/l are not in higher risk of death.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc16031162
- 003
- CZ-PrNML
- 005
- 20200630083238.0
- 007
- ta
- 008
- 161101s2015 xr f 000 0|ENG||
- 009
- AR
- 024 7_
- $a 10.33549/physiolres.933179 $2 doi
- 035 __
- $a (PubMed)26680668
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a ENG
- 044 __
- $a xr
- 100 1_
- $a Pikhart, Hynek $u Department of Epidemiology and Public Health, University College London, London, United Kingdom $7 xx0107140
- 245 10
- $a Association between fasting plasma triglycerides, all-cause and cardiovascular mortality in Czech population. Results from the HAPIEE study / $c H. Pikhart, J. A. Hubáček, A. Peasey, R. Kubínová, M. Bobák
- 520 9_
- $a Dyslipidemia is the risk factor of cardiovascular disease, but the relationship between the plasma triglyceride (TG) levels and total/cardiovascular mortality has not yet been analyzed in Slavs. The aim of our study was to analyze the association between the fasting TG levels and all-cause/cardiovascular mortality. We have examined 3,143 males and 3,650 females, aged 58.3+/-7.1 years. 729 deaths (274 cardiovascular deaths) have been registered during up to 11.8 years of follow-up. Age-sex adjusted all-cause mortality was higher in individuals with TG values 3.01-4.00 mmol/l (HR 1.37, 95 % CI 1.02-1.83, P=0.035) and over 4.00 mmol/l (HR 1.66, 95 % CI 1.21-2.27, P=0.002) when compared with a reference group (TG 1.41-1.80 mmol/l). Elevated risk remains significant when adjusted for education, marital status and unemployment. When further adjusted for smoking, BMI and dyslipidemia interventions, HR for those in above 4.00 mmol/l group decreased (1.42, P=0.04). The results have been similar when cardiovascular mortality has been examined, however, results reached statistical significance only for the TG over 4.0 mmol/l (P=0.028). Our results confirmed that enhanced plasma levels of plasma triglycerides are dose dependently associated with increased risk of all-cause mortality, however, it seems that individuals with TG values 1.8-3.0 mmol/l are not in higher risk of death.
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a kardiovaskulární nemoci $x krev $x mortalita $7 D002318
- 650 _2
- $a omezení příjmu potravy $x krev $7 D005215
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a následné studie $7 D005500
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a mortalita $x trendy $7 D009026
- 650 12
- $a surveillance populace $x metody $7 D011159
- 650 _2
- $a rizikové faktory $7 D012307
- 650 _2
- $a triglyceridy $x krev $7 D014280
- 651 _2
- $a Česká republika $x epidemiologie $7 D018153
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a multicentrická studie $7 D016448
- 655 _2
- $a Research Support, N.I.H., Extramural $7 D052061
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Hubáček, Jaroslav, $d 1966- $7 nlk20050169367 $u Laboratory for Atherosclerosis Research, Center for Experimental Medicine, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
- 700 1_
- $a Peasey, A. $u Department of Epidemiology and Public Health, University College London, London, United Kingdom
- 700 1_
- $a Kubínová, Růžena, $d 1947- $7 xx0082854 $u National Institute of Public Health, Prague, Czech Republic
- 700 1_
- $a Bobák, Martin, $d 1963- $7 xx0092245 $u Department of Epidemiology and Public Health, University College London, London, United Kingdom
- 773 0_
- $w MED00003824 $t Physiological research $x 1802-9973 $g Roč. 64, Suppl 3 (2015), s. S355-S361
- 773 0_
- $t Supplement on the occasion of the conference triglyceride and atherosclerosis $g (2015), s. S355-S361 $w MED00191410
- 856 41
- $u http://www.biomed.cas.cz/physiolres/ $y domovská stránka časopisu
- 910 __
- $a ABA008 $b A 4120 $c 266 $y 4 $z 0
- 990 __
- $a 20161101 $b ABA008
- 991 __
- $a 20200630083235 $b ABA008
- 999 __
- $a ok $b bmc $g 1172736 $s 955820
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2015 $b 64 $c Suppl 3 $d S355-S361 $i 1802-9973 $m Physiological research $n Physiol. Res. (Print) $x MED00003824
- BMC ##
- $a 2015 $d S355-S361 $m Supplement on the occasion of the conference triglyceride and atherosclerosis $x MED00191410
- LZP __
- $b NLK118 $a Pubmed-20161101